Medicines Company

Gene Therapy M&A Appetite Provides Lift After Audentes Deal
Gene Therapy M&A Appetite Provides Lift After Audentes Deal
Yahoo/Bloomberg
gene therapy
Astellas
Audentes Therapeutics
M&A
Novartis
Medicines Company
Flag link:
Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for Amgen
Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for Amgen
Motley Fool
Novartis
Medicines Company
M&A
inclisiran
Flag link:
Why Novartis Is Buying The Medicines Company For $9.7 Billion
Why Novartis Is Buying The Medicines Company For $9.7 Billion
Forbes
Novartis
Medicines Company
M&A
inclisiran
Flag link:
Amarin for $20B? Novartis' MedCo deal drives fresh buyout rumors for Vascepa's maker
Amarin for $20B? Novartis' MedCo deal drives fresh buyout rumors for Vascepa's maker
Fierce Pharma
Amarin
M&A
Novartis
Medicines Company
Gilead Sciences
Flag link:
Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co
Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co
Endpoints
Mark Timney
Purdue Pharma
Novartis
Medicines Company
M&A
Flag link:
The Medicines Company Surges on Positive Drug Trial Results
The Medicines Company Surges on Positive Drug Trial Results
Motley Fool
Medicines Company
inclisiran
clinical trials
Flag link:
MedCo's PCSK9 challenger steals the show at ESC with winning data
MedCo's PCSK9 challenger steals the show at ESC with winning data
Fierce Pharma
Medicines Company
ESC
PCSK9 inhibitors
inclisiran
Repatha
Praluent
European Society of Cardiology
Flag link:
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Amgen
Regeneron
Sanofi
Praluent
Repatha
Medicines Company
PCSK9 inhibitors
inclisiran
Flag link:
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
Xconomy
PCSK9 inhibitors
Medicines Company
inclisiran
insurers
Flag link:
Medicines Company's PCSK9 drug hits phase 3 efficacy goals
Medicines Company's PCSK9 drug hits phase 3 efficacy goals
Fierce Biotech
Medicines Company
inclisiran
clinical trials
Flag link:
How This Company Is Taking on Amgen
How This Company Is Taking on Amgen
Motley Fool
Amgen
Medicines Company
Repatha
inclisiran
Flag link:
Amgen Blew It…For Medicines Co., Esperion Too
Amgen Blew It…For Medicines Co., Esperion Too
Barron's
Amgen
Medicines Company
Esperion Therapeutics
Repatha
inclisiran
Flag link:
Medicines Co. sells off cardiovascular drugs to Italy's Chiesi
Medicines Co. sells off cardiovascular drugs to Italy's Chiesi
BioPharma Dive
Medicines Company
Cardiovascular
Italy
M&A
Chiesi
Flag link:
Drugmaker Medicines Co. Is Said to Explore a Sale
Drugmaker Medicines Co. Is Said to Explore a Sale
Bloomberg
Medicines Company
M&A
Flag link:
Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis
Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis
Seeking Alpha
Amgen
Regeneron
Medicines Company
Isis Pharmaceuticals
Gilead Sciences
Biogen
Flag link:
Why Amgen, Inc Should Acquire Alnylam
Why Amgen, Inc Should Acquire Alnylam
Bidness, ETC
Amgen
Alnylam
M&A
ALN-PCSsc
Medicines Company
Flag link:
FDA approves Medicines Co's blood clot drug after a decade
FDA approves Medicines Co's blood clot drug after a decade
Yahoo/Reuters
FDA
Medicines Company
Cangrelor
Flag link:
FDA approves the Medicines Co's pain drug device Ionsys
FDA approves the Medicines Co's pain drug device Ionsys
Yahoo/Reuters
FDA
Medicines Company
devices
painkillers
Ionsys
opioids
Flag link:
After PhIII odyssey, the FDA finally gives Medicines Co a thumbs-up for cangrelor
After PhIII odyssey, the FDA finally gives Medicines Co a thumbs-up for cangrelor
Fierce Biotech
FDA
Medicines Company
bloodthinners
Cangrelor
Flag link:
Medicines Co. prevails in patent challenge from Mylan
Medicines Co. prevails in patent challenge from Mylan
Seeking Alpha
Medicines Company
patents
Mylan Labs
Angiomax
Flag link:

Pages